Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2020

Sep 18, 2020

34412_dirs_2020-09-18_705dd2d2-1efc-41ca-8424-4488f2525155.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-09-15

Reporting Person: DUBIN STEVE (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $16.11 2030-09-17 Common Stock (30000) Direct

Footnotes

F1: The shares of common stock subject to the option shall vest in equal installments on each of the thirty-six (36) monthly anniversaries of the vesting commencement date, provided that the reporting person remains in continuous service as of the applicable vesting date.